Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
||
|
WHO-ATC |
V03AB37
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
||
|
NDF-RT |
N0000191873
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
||
|
FDA ORPHAN DRUG |
445714
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
N0000183512
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | Antibodies, Monoclonal, Humanized [Chemical/Ingredient] | ||
|
C128646
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
SUB166928
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
m11895
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
9698
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
97RWB5S1U6
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
97RWB5S1U6
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
5055
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
Idarucizumab
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
CHEMBL3544996
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
1362509-93-0
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
DB09264
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
CD-15
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
Idarucizumab
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
100000157840
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | |||
|
1716191
Created by
admin on Mon Mar 31 22:39:46 GMT 2025 , Edited by admin on Mon Mar 31 22:39:46 GMT 2025
|
PRIMARY | RxNorm |
ACTIVE MOIETY